Company Overview and News

 
Avrupa Minerals Reports Positive Drilling Results from Entre Matinhas target on the Alvito IOCG Project, Portugal

9h globenewswire
VANCOUVER, British Columbia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Avrupa Minerals Ltd. (AVU:TSXV) (US OTC:AVPMF) (FRANKFURT:8AM) is pleased to report final results from the recently-completed first pass, exploration drill project at the Alvito iron oxide copper-gold (IOCG) Project in south Portugal. The program totaled 2,437.5 meters of diamond drilling from 18 holes in eight separate target areas around the Alvito license.
AVU OZMLF AVPMF OZL

2
ASX hits two-week high as miners advance

2018-09-19 theage.com.au
Australian shares advanced amid more positive trade headlines as the major banks and miners lifted the market to its highest close in two weeks.
RIO BLT RIO LYSCF KMD REG RTPPF RTNTF MS KMD KTHDY BHPBF TPPTY TPM OZMLF TPGTF BHP RIO LYSDY BBL BHP OZL BHPLF JRHHY EHE JHC

2
ASX hits two-week high as miners advance

2018-09-19 smh.com.au
Australian shares advanced amid more positive trade headlines as the major banks and miners lifted the market to its highest close in two weeks.
RIO BLT RIO LYSCF KMD REG RTPPF RTNTF MS KMD KTHDY BHPBF TPPTY TPM OZMLF TPGTF BHP RIO LYSDY BBL BHP OZL BHPLF JRHHY EHE JHC

 
Cassini Resources discovers extension body at Nebo deposit

2018-09-17 proactiveinvestors.com.au
Cassini Resources Ltd (ASX:CZI) has discovered a significant new body of mineralisation, named the Angie Lode, to the east of the Nebo deposit, within the West Musgrave Project, Western Australia.
OZMLF OZL CSSQF CZI

2
ASX drops to one-month low on weak metals

2018-09-05 theage.com.au
The sharemarket fell to a one-month low on Wednesday as the looming threat of further US tariffs against China weighed on investors.
RIO RIO CTXAY IGO IIDDY CTX RTPPF OZMLF RIO CTXAF RTNTF SBM OZL

2
ASX drops to one-month low on weak metals

2018-09-05 smh.com.au
The sharemarket fell to a one-month low on Wednesday as the looming threat of further US tariffs against China weighed on investors.
RIO RIO CTXAY IGO IIDDY CTX RTPPF OZMLF RIO CTXAF RTNTF SBM OZL

 
Downer wins $286m Millmerran mine management contract

2018-09-05 australianmining.com.au
Downer EDI has been awarded a contract extension for its mining services at the Commodore open cut coal mine in South East Queensland.
DOW OZMLF DNERY DOW OZL

 
OZ Minerals expands Eloise JV with Minotaur

2018-09-04 australianmining.com.au
OZ Minerals and Minotaur Exploration are to expand exploration activity at the Eloise joint venture (JV) in Queensland.
OZMLF MEP OZL

 
Metricon continues to want to be the most awarded SA builder

2018-09-03 perthnow.com.au
A LEADING national home builder is to move its South Australia headquarters to the former home of a well-known mining company along the city’s fringe.
OZMLF OZL

15
Cobalt Miners News For The Month Of August 2018

2018-08-23 seekingalpha
Cobalt miner news - BHP seeking to add cobalt sulphate from Nickel West operation. China Molybdenum net profit set to surge between 271.21% and 295.16%.
SIE PIO CLA PANRF BLT CCZ PAN HAV MCR KBGCF CTM AXE ECSIF IGO VIC BAR AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR CDU RGARF CHK MCRZY FTMDF KAT RER BBL CSSQF BHPLF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF GAL CZI AMSLF BPLNF HMI POS AUZ RNX GME FQVLF AQR PTNUF FT BHPBF HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM BHP CNJ AZRMF HLPCF BPL BHP OZL ARV

 
The sure signs business is looking up in SA: William Buck Survey of Business Expectations in review

2018-08-20 perthnow.com.au
SOUTH Australian businesses are riding a wave of confidence, and they have every reason to be optimistic about the state’s future.
OZMLF OZL

 
Cassini Resources adds Tinci Materials chairman to registry with $4.2 million raising

2018-08-17 proactiveinvestors.com.au
Cassini Resources Ltd (ASX:CZI) (FRA:ICR) has completed a $4.2 million placement to high-quality investors, adding Guangzhou Tinci Materials Technology Co Ltd chairman Xu Jinfu as a cornerstone investor as it progresses the West Musgrave project feasibility study with partner OZ Minerals Limited (ASX:OZL) (FRA:OXR) (OTCMKTS:OZMLF).
OZMLF OZL CSSQF CZI

 
Cassini Resources adds Tinci Materials chairman to registry with $4.2 million raising

2018-08-17 proactiveinvestors.com.au
Cassini Resources Ltd (ASX:CZI) has completed a $4.2 million placement to high-quality investors, adding Guangzhou Tinci Materials Technology Co Ltd chairman Xu Jinfu as a cornerstone investor as it progresses the West Musgrave project feasibility study with partner OZ Minerals Limited (ASX:OZL).
OZMLF OZL CSSQF CZI

 
OZ Minerals Ltd. 2018 Q2 - Results - Earnings Call Slides

2018-08-16 seekingalpha
The following slide deck was published by OZ Minerals Ltd. in conjunction with their 2018 Q2 earnings call.
OZMLF OZL

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

5h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

CUSIP: Q7161P106